TECHNOLOGY
TECHNOLOGY
TECHNOLOGY
INVESTORS
INVESTORS
TECHNOLOGY
RESOURCES
RESOURCES
RESOURCES
TECHNOLOGY
TECHNOLOGY
TECHNOLOGY
TECHNOLOGY
RESOURCES
Measuring Therapy Effectiveness Through Sensing and Data Control
Find out how we are transforming the medical industry through continuous sensing, computing and transmission to provide the configurable data that physicians need.
We've started with intraocular pressure (IOP) sensing to help assess glaucoma therapy effectiveness.
Press Releases
Sept. 1, 2020
Injectsense Receives FDA Breakthrough Device Program Designation
for Continuous IOP Monitoring for Glaucoma
Media Coverage
An Update on Implantable IOP monitoring
Injectsense takes RPM to Ophthalmology & Beyond (paywall-protected)
The Ophthalmologist March 12, 2020
Organ to Cloud Technology is Here
Glaucoma Physician Dec. 1, 2019
Sensor for Continuous IOP Monitoring
Injectable Sensor Designed to Keep an Eye on Glaucoma
Eyewire News Oct. 9, 2019
Injectsense Demonstrates Animal-to-Cloud IOP Sensing Pathway
Technology
Our smart sensor is a self-anchoring platform that interfaces well with media (blood, tissue, other fluids) without interfering with the electronics that support the sensing, computing and transmission of data.
Investors
Injectsense received Series B funding in April of 2019, and is currently engaged in fundraising for Series C.
The Injectsense Difference
Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise.
CAUTION - Investigational Device. Limited by Federal law to investigational use.
.